Benuvia Operations, LLC.
Mohammed Kabir has over 30 years of work experience in the pharmaceutical industry. Mohammed has held several roles at different companies, including Benuvia Operations, LLC., Akorn Pharmaceuticals, Apotex Inc., Seneca College of Applied Arts and Technology, Somatec Pharmaceuticals Ltd, National Laboratories Limited, and Square Pharmaceuticals, Dhaka. Mohammed'smost recent position was as the Sr. Director of Formulation R&D at Benuvia Operations, LLC. Prior to that, they worked as a Director, Associate Director, and Manager of Formulation R&D at Akorn Pharmaceuticals. Mohammed also served as a Sr. Scientific Leader (Manager), Formulation at Apotex Inc. In addition to their industry experience, Mohammed Kabir has also worked as an Instructor of "Pharmaceutical Manufacturing Technology" and "Product Formulation" at Seneca College. Overall, their work experience includes expertise in formulation development, process development, manufacturing of various dosage forms, analytical methodologies, and working with CDMOs and CMOs.
Mohammed Kabir passed the Equivalence Exam from the Pharmacy Examining Board of Canada in 1996. Mohammed also completed their B.Pharm and M.Pharm degrees in Pharmacy from the University of Dhaka between the years 1983 and 1990.
This person is not in any offices
Benuvia Operations, LLC.
Benuvia Manufacturing is a leading developer and manufacturer of high-purity, pharmaceutical cannabinoid ingredients and products. We offer a comprehensive suite of solutions for pharmaceutical, biotechnology, and consumer product companies to achieve their development and commercial needs. We have over 100,000 square feet of state-of-the-art research, development and manufacturing space across two cGMP facilities in Chandler, Arizona and Round Rock, Texas. We began manufacturing pharmaceutical grade cGMP pure quality cannabidiol (CBD) in 2009 and our Round Rock facility has produced CBD since 2014 (DMF 32552). Today, Round Rock is the only CBD active pharmaceutical ingredient (API) contract manufacturing site in the U.S. producing an FDA approved cannabinoid drug (SYNDROS®). Our facilities are DEA and FDA registered cGMP production sites and are fully regulated and compliant with all DEA, EPA, and OSHA requirements. Further information is available at www.benuviamanufacturing.com.